Surgical Oncologist at @InovaSchar 🦈 by way of @UofLDeptofSurg #CGSO and @TempleSurgery residency 😷🔪💉 @DukeAlumni '13 💙😈🏀 dog mom 🐕
Louisville, KY
Joined September 2010
- Tweets4.1K
- Following270
- Followers252
- Likes1.3K
Pinned Tweet
@InovaSchar HPB multi-disciplinary surg onc/med onc team wearing purple today for #PancreasCancer awareness #NPFColorItPurple @NatPancFdn @InovaHealth
Meredith Gunder, MD, MS retweeted
Adjuvant chemotherapy with cisplatin and gemcitabine compared to standard of care after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1/AIO-HEP-0112 trial)
#ESMO26 #cancer #oncology #MedX @OncoAlert
annalsofoncology.org/article…
Meredith Gunder, MD, MS retweeted
NEVER STOP LEARNING
Listen to a quick pod! Some say why, others say why not?!
Journal Review in Surgical Oncology: Gastric Cancer
behindtheknife.org/podcast/j…
With the fabulous @vreelant @usarmydoc24 @lexyadams16 @joebrod5 @gistgalen
Meredith Gunder, MD, MS retweeted
Despite its clinical significance, adjacent organ invasion is not included as a determinant in the AJCC staging or NCCN resectability criteria
This study evaluated the safety & efficacy of multivisceral resection vs standard resection jogs.org/article/S1091-255X(…
#Cancer #Outcomes
Meredith Gunder, MD, MS retweeted
The Landmark Series: Neoadjuvant Therapy for Patients with Resectable #GastroesophagealJunction Adenocarcinomas @MPettigrewMD @DrNCoburn @MPorembka
ow.ly/RBlt50ZZTt7
@DrSabha
@SyedAAhmad5
@SocSurgOnc
Meredith Gunder, MD, MS retweeted
#daraxonrasib clinical outcomes by allele in #RASolute302 from FDA NDA review.
These data perpetuate unresolved questions:
- is RASi as effective for KRAS WT; K12R? See Table 24; Fig 11.
- is 300 mg necessary for maximal clinical benefit? no data provided comparing 200 vs 300.
Meredith Gunder, MD, MS retweeted
Featured: Great Debate: Should Surgery Be Omitted in the Management of #GastroesophagealJunction Cancers? @MeredithGunder
ow.ly/jrsC50ZWgZA
@DenboJw
@SyedAAhmad5
@SocSurgOnc
Meredith Gunder, MD, MS retweeted
The incidence of early-onset colorectal cancer has doubled in the last 25 years.
This is a fantastic @NEJM review article on #EOCRC that I stumbled across today. It's 5 years old, but @FASinicropeMD summarizes the topic wonderfully.
It covers risk factors, preventative factors, and the role of the microbiome. The graphics are excellent.
Smoking and obesity may be obvious contributors, but there's also an alarming association with the Western diet (red meat, ultra-processed foods, etc).
The trends in this review stop at 2016. A scary revelation is that incidence and annual percent change have kept going up since then:
2016: incidence 8.1 per 100k, APC 3.4%
2023: 11.5 per 100k, APC 9.9%
Article:
nejm.org/doi/full/10.1056/NE…
SEER explorer:
seer.cancer.gov/statistics-n…
Systematic reviews:
pubmed.ncbi.nlm.nih.gov/4219…
pubmed.ncbi.nlm.nih.gov/3722…
Pooled analysis of 3 large European cohorts:
pubmed.ncbi.nlm.nih.gov/4142…
Meredith Gunder, MD, MS retweeted
Among patients with resectable and borderline-resectable #PancreaticCancer treated with neoadjuvant chemotherapy, adding #Radiotherapy was associated with improved pathologic response, but was not associated with improved overall survival.
ja.ma/3UZcFIB
Meredith Gunder, MD, MS retweeted
Join SSO, SMeO, and BSSO for this international webinar!
Gain firsthand knowledge of current controversies, regional practice patterns, and opportunities to improve the delivery of multidisciplinary gallbladder cancer care.
Secure your spot: ow.ly/6wpP50ZGHiJ
Meredith Gunder, MD, MS retweeted
In resected #GastricCancer, KRAS and PIK3CA alterations in the primary tumor were associated with worse disease-free survival, supporting a role for genomic profiling in postoperative risk stratification.
ja.ma/3SgJWhw
Meredith Gunder, MD, MS retweeted
#Melanoma Surgeons! Please consider participating in this short IRB approved anonymous survey on sentinel lymph node biopsy @FoxChaseCancer
Share your approach
studies.fccc.edu/redcap/surv…
@SocSurgOnc @AmColSurgCancer @MelanomaReAlli @CureMelanoma @AcademicSurgery @UnivSurg
🤖 Made with AI
Meredith Gunder, MD, MS retweeted
Surveillance discontinuation after 5 years in select patients with stable IPMNs could save an estimated $136,000 annually. ovid.com/10.1097/SLA.0000000…
Meredith Gunder, MD, MS retweeted
Perspective by Josiah D. Rich, MD, MPH, Karla Thornton, MD, MPH, and Matthew J. Akiyama, MD: National Elimination of Hepatitis C — The Case for Starting in Prisons and Jails nej.md/4bGUI7d
#HealthPolicy #PublicHealth
ALT A quote in purple text on a white background reads as follows: "If we focus on incarcerated populations and people on probation or parole, a large proportion of people with HCV in the United States could be diagnosed and cured, which could improve their health and prevent transmission."
Meredith Gunder, MD, MS retweeted
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer @nejm nejm.org/doi/full/10.1056/NE…
Meredith Gunder, MD, MS retweeted
#AudioVisualAbstract : Real-World Single-Center Experience with Neoadjuvant Gemcitabine, Cisplatin, and Durvalumab in Borderline Resectable #Cholangiocarcinoma @Yawwenyy @TELL_Starlinger
ow.ly/A7tG50ZspxE
@NabeelZafarMD
@SyedAAhmad5
Meredith Gunder, MD, MS retweeted
Over the past 30 years, overall survival for patients with neuroendocrine liver metastases has improved substantially, with 5-year survival increasing from 45% to 75%. ovid.com/10.1097/SLA.0000000…
Meredith Gunder, MD, MS retweeted
Staging Laparoscopy in Gastric Cancer Patients Treated with Curative Intent: A European GASTRODATA Cohort Study @annsurgoncol link.springer.com/article/10…
Meredith Gunder, MD, MS retweeted
#AudioVisualAbstract : #StagingLaparoscopy in #GastricCancer Patients Treated with Curative Intent: A European GASTRODATA Cohort Study
ow.ly/tBlR50ZkNuW
@AnishJayJain
@SyedAAhmad5
Meredith Gunder, MD, MS retweeted
July Issue: Consensus Guidelines on Perioperative Care in Primary Retroperitoneal #Sarcoma Surgery @Pllcg3 @CrisyRoland
ow.ly/5rJu50ZkQcZ
#SarcomaAwarenessMonth
@MeredithGunder
@SyedAAhmad5
@SocSurgOnc
Meredith Gunder, MD, MS retweeted
Honored to be part of this JAMA Surgery publication.
Our multicenter study highlights the value of DUPAN-2 in CA19-9 nonexpressor PDAC.
Hoping to raise global awareness of DUPAN-2 in PDAC care. ＃JAMAsurg
jamanetwork.com/journals/jam…
